Lv61
2370 积分 2023-06-20 加入
Overcoming Primary and Acquired Resistance to Immunotherapy in Non–Small Cell Lung Cancer: Mechanisms, Challenges, and Emerging Strategies
1小时前
求助中
Pancreatic cancer
18天前
已完结
Provider Follow-Up and Adherence to Imaging Surveillance Recommendations for Lung Cancer Survivors in a Nationwide Health Care System
1个月前
已关闭
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
1个月前
已完结
A Roadmap to Precision Immunotherapy for Early-Stage Non–Small Cell Lung Cancer
1个月前
已完结
Coronavirus disease 2019 infection reduces EGFR‐TKI efficacy in non‐small cell lung carcinoma: Real‐world evidence from a multicenter propensity‐matched cohort
2个月前
已关闭
Drug Development in Non-Oncogene-Addicted Non-Small Cell Lung Cancer
2个月前
已关闭
EGFR signaling pathway as therapeutic target in human cancers
3个月前
已完结
Prognostic impact and treatment options for EGFR-mutant non-small cell lung cancer with concurrent EGFR amplification
3个月前
已关闭
The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation
3个月前
已关闭
皖公网安备34019202002308
